Thursday, February 11, 2021

Pipeline Therapeutics Finds $80M In Series C Funding

San Diego-based Pipeline Therapeutics, a biopharmaceuticals firm focused on small molecules for neuroregeneration, said on Thursday that it has raised $80M in its Series C funding. The funding included Perceptive Advisors, Franklin Templeton, Casdin Capital, Samsara BioCapital, Suvretta Capital, Red Tree Venture Capital, plus Versant Ventures, Sectoral Asset Management, Cleva Pharma (a Brace Pharma affiliate), Hadean Ventures, RBV Capital and Helicase Venture, as well as several other undisclosed investors. The lead was a "healthcare-focused new investor", according to the company. The company said it will use the new funding to advance development candidates for a number of its programs. Pipeline Therapeutics is led by President and CEO Carmine Stengone. More information »